130 related articles for article (PubMed ID: 36178187)
1. Coronavirus disease 2019 (COVID-19) in patients before, during, or after lung irradiation, and serum SP-A and SP-D levels.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Okada M
Thorac Cancer; 2022 Nov; 13(22):3200-3207. PubMed ID: 36178187
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis.
Sasaki R; Soejima T; Matsumoto A; Maruta T; Yamada K; Ota Y; Kawabe T; Nishimura H; Sakai E; Ejima Y; Sugimura K
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):301-7. PubMed ID: 11380215
[TBL] [Abstract][Full Text] [Related]
3. Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha.
Halme M; Hallman M; Ruotsalainen T; Piilonen A; Taskinen E; Pekonen M; Maasilta P; Mattson K
Lung Cancer; 1999 Jan; 23(1):39-52. PubMed ID: 10100145
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy.
Xu L; Jiang J; Li Y; Zhang L; Li Z; Xian J; Jiang C; Diao Y; Su X; Xu H; Zhang Y; Zhang T; Yang Z; Tan B; Li H
Cancer Med; 2019 May; 8(5):2599-2611. PubMed ID: 30897289
[TBL] [Abstract][Full Text] [Related]
5. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.
Yamashita H; Kobayashi-Shibata S; Terahara A; Okuma K; Haga A; Wakui R; Ohtomo K; Nakagawa K
Radiat Oncol; 2010 May; 5():32. PubMed ID: 20459699
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis.
Takahashi H; Imai Y; Fujishima T; Shiratori M; Murakami S; Chiba H; Kon H; Kuroki Y; Abe S
Eur Respir J; 2001 Mar; 17(3):481-7. PubMed ID: 11405529
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy.
Matsuno Y; Satoh H; Ishikawa H; Kodama T; Ohtsuka M; Sekizawa K
Med Oncol; 2006; 23(1):75-82. PubMed ID: 16645232
[TBL] [Abstract][Full Text] [Related]
10. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076
[TBL] [Abstract][Full Text] [Related]
11. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
[TBL] [Abstract][Full Text] [Related]
13. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury.
Morgan GW; Breit SN
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):361-9. PubMed ID: 7836090
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.
Yamaguchi H; Soda H; Nakamura Y; Takasu M; Tomonaga N; Nakano H; Doi S; Nakatomi K; Nagashima S; Takatani H; Fukuda M; Hayashi T; Tsukamoto K; Kohno S
Cancer Chemother Pharmacol; 2011 Feb; 67(2):331-8. PubMed ID: 20401612
[TBL] [Abstract][Full Text] [Related]
15. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.
Taghian AG; Assaad SI; Niemierko A; Kuter I; Younger J; Schoenthaler R; Roche M; Powell SN
J Natl Cancer Inst; 2001 Dec; 93(23):1806-11. PubMed ID: 11734597
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
18. The relationship of radiation pneumonitis to treated lung volume in breast conservation therapy.
Minor GI; Yashar CM; Spanos WJ; Jose BO; Silverman CL; Carrascosa LA; Farmer M; Paris KJ
Breast J; 2006; 12(1):48-52. PubMed ID: 16409586
[TBL] [Abstract][Full Text] [Related]
19. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
20. A Potential Biomarker for Predicting the Risk of Radiation-Induced Fibrosis in the Lung.
Groves AM; Williams JP; Hernady E; Reed C; Fenton B; Love T; Finkelstein JN; Johnston CJ
Radiat Res; 2018 Nov; 190(5):513-525. PubMed ID: 30117783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
